Skip to content

Managing Infected Pancreatic Necrosis In China: a Register-Based Study

Managing Infected Pancreatic Necrosis In China: a Register-Based Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041268
Enrollment
Unknown
Registered
2020-12-23
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

case series:Nil

Sponsors

East Region Military Command General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Informed consent form obtained from the patient or next of kin; 2. Aged between 18 to 70 years; 3. Symptoms and signs of acute pancreatitis based on abdominal pain suggestive of AP, serum amylase at least three times the upper limit of normal, and/or characteristic findings of AP on computed tomography or less commonly magnetic resonance imaging (MRI) or transabdominal ultrasonography according to the Revised Atlanta Criteria; 4. Infected necrosis is diagnosed by gas in the necrotic collection on imaging, positive culture of a fine-needle aspiration (FNA), or unequivocal clinical signs of infection.

Exclusion criteria

Exclusion criteria: 1. Pregnant pancreatitis; 2. Receiving intervention or early surgery due to abdominal compartment syndrome or other reasons before admission ; 3. Patients with a known history of severe cardiovascular, respiratory, renal, hepatic, hematologic, or immunologic disease defined as (1) greater than New York Heart Association class III heart failure, (2) active myocardial ischemia or (3) cardiovascular intervention within previous 60 days, (4) history of cirrhosis or (5) chronic kidney disease with creatinine clearance< 40 mL/min, or (6) chronic obstructive pulmonary disease with requirement for home oxygen. 4. Patients with preexisting immune disorders such as AIDS.

Design outcomes

Primary

MeasureTime frame
The incidence of in-hospital death and major complications;

Countries

China

Contacts

Public ContactZhihui Tong

General Hospital of the PLA Eastern Theater Command

ctgchina@medbit.cn+86 25-80860007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026